Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
Severe alcoholic hepatitis (SAH), when it manifests as acute-on-chronic liver failure (ACLF), is associated with a high risk of short-term mortality. A significant factor in its development is the alteration of gut microbiota, which has been identified as a key element in the disease's pathogenesis. Modulating this gut microbiota has been proposed as a potential therapeutic approach (1).
The clinical trial NCT03827772 - Fecal Microbiota Transplantation (FMT) & Alcoholic hepatitis is an open-label non-randomized treatment trial evaluating the impact of fecal microbiota transplantation (FMT) or standard care…